MiR-196a exerts its oncogenic effect in glioblastoma multiforme by inhibition of IκBα both in vitro and in vivo

Neuro-Oncology

Volumn 16, Issue 5, 2014, Pages 652-661

  Yang, Guang ^a,b   Han, Dayong ^a,b   Chen, Xin ^a,b   Zhang, Daming ^a,b   Wang, Lu ^b   Shi, Chen ^e   Zhang, Weiguang ^a,b   Li, Chenguang ^a,b   Chen, Xiaofeng ^a,b   Liu, Huailei ^a,b   Zhang, Dongzhi ^a,b   Kang, Jianhao ^a,b   Peng, Fei ^a,b   Liu, Ziyi ^a,b   Qi, Jiping ^b   Gao, Xin ^d   Ai, Jing ^b   Shi, Changbin ^c   Zhao, Shiguang ^a,b  

^a THE FIRST AFFILIATED HOSPITAL OF HARBIN MEDICAL UNIVERSITY   (China)

^b HARBIN MEDICAL UNIVERSITY   (China)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d KING ABDULLAH UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Saudi Arabia)

^e UNIVERSITY OF CHICAGO   (United States)

Author keywords

Apoptosis; Glioblastoma; I B ; MiR 196a; Tumor growth

Indexed keywords

ANTAGOMIR; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MICRORNA; MICRORNA 196A; UNCLASSIFIED DRUG; I KAPPA B; MIRN196 MICRORNA, HUMAN;

3' UNTRANSLATED REGION; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER TISSUE; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GLIOBLASTOMA; GLIOMA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LUCIFERASE ASSAY; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY MECHANISM; TUMOR GROWTH; TUMOR VOLUME; TUMOR XENOGRAFT; UPREGULATION; ANIMAL; ANTAGONISTS AND INHIBITORS; BAGG ALBINO MOUSE; BRAIN TUMOR; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MIDDLE AGED; SURVIVAL; TUMOR CELL LINE;

ANIMALS; APOPTOSIS; BRAIN NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOBLASTOMA; HUMANS; I-KAPPA B PROTEINS; MALE; MICE; MICE, INBRED BALB C; MICRORNAS; MIDDLE AGED; NF-KAPPA B; SURVIVAL ANALYSIS;

EID: 84899421350     PISSN: 15228517     EISSN: 15235866     Source Type: Journal    
DOI: 10.1093/neuonc/not307     Document Type: Article

References (41)

1. Purow B Schiff D. Advances in the genetics of glioblastoma: Are we reaching critical mass?. Nat Rev Neurol. 2009;5(8):419-426
2. Park JKHodgesT ArkoL et al. Scale to predict survival after surgery for recurrent glioblastoma multiforme. J Clin Oncol. 2010;28(24): 3838-3843
3. KongYW Ferland-McCollough D Jackson TJ et al. microRNAsin cancer management. Lancet Oncol. 2012;13(6):e249-e258
4. Yang G Zhang R Chen X et al. MiR-106a inhibits glioma cell growth by targeting E2F1 independent of p53 status. J Mol Med (Berl). 2011; 89(10):1037-1050
5. Ma X Yoshimoto K Guan Y et al. Associations between microRNA expression and mesenchymal marker gene expression in glioblastoma. Neuro Oncol. 2012;14(9):1153-1162
6. ChenC ZhangY ZhangL et al. MicroRNA-196: Critical rolesand clinical applications in Development and cancer. J Cell Mol Med. 2011;15(1): 14-23
7. Wang K Li J Guo H et al. MiR-196a binding-site SNP regulates RAP1A expression contributing to esophageal squamous cell carcinoma risk and metastasis. Carcinogenesis. 2012;33(11):2147-2154
8. Sun M Liu XH Li JH et al. MiR-196a is upregulated in gastric cancerand promotes cell proliferation by downregulating p27(kip1). Mol Cancer Ther. 2012;11(4):842-852
9. Bloomston M Frankel WL Petrocca F et al. MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. JAMA. 2007;297(17):1901-1908
10. Niinuma T Suzuki H Nojima M et al. Upregulation of miR-196a and HOTAIR Drive Malignant Character in Gastrointestinal Stromal Tumors. Cancer Res. 2012;72(5):1126-1136
11. Guan Y Mizoguchi M Yoshimoto K et al. MiRNA-196 is upregulated in glioblastoma but not in anaplastic astrocytoma and has prognostic significance. Clin Cancer Res. 2010;16(16):4289-4297
12. Wang J Song Y Zhang Y et al. Cardiomyocyte overexpression of miR-27b induces cardiac hypertrophy and dysfunction in mice. Cell Res. 2012;22(3):516-527
13. Wu Q Jin H Yang Z et al. MiR-150 promotes gastric cancer proliferation by negatively regulating the pro-Apoptotic gene EGR2. Biochem Biophys Res Commun. 2010;392(3):340-345
14. Bredel M Scholtens DM Yadav AK et al. NFKBIA deletion in glioblastomas. N Engl JMed. 2011;364(7):627-637
15. Tsai KW Liao YL Wu CW et al. Aberrant expression of miR-196a in gastric cancers and correlation with recurrence. Genes Chromosomes Cancer. 2012;51(4):394-401
16. Hui AB ShiW Boutros PC et al. Robust global micro-RNA profiling with formalin-fixed paraffin-embedded breast cancer tissues. Lab Invest. 2009;89(5):597-606
17. Maru DM Singh RR Hannah C et al. MicroRNA-196a is a potential marker of progression During Barretts metaplasia-dysplasiainvasive adenocarcinoma sequence in esophagus. Am J Pathol. 2009;174(5):1940-1948
18. Ma R YanW Zhang G et al. Upregulation of miR-196b confers a poor prognosis in glioblastoma patients via inducing a proliferative phenotype. PLoS One. 2012;7(6):e38096
19. Lakomy R Sana J Hankeova S et al. MiR-195 miR-196b miR-181c miR-21 expression levels and O-6-methylguanine-DNA methyltransferase methylation status are associated with clinical outcome in glioblastoma patients. Cancer Sci. 2011;102(12):2186-2190
20. Luthra R Singh RR Luthra MG et al. MicroRNA-196a targets annexin A1: A microRNA-mediated mechanism of annexin A1 downregulation in cancers. Oncogene. 2008;27(52):6667-6678
21. Li Y Zhang M Chen H et al. Ratio of miR-196 s to HOXC8 messenger RNA correlates with breast cancer cell migration and metastasis. Cancer Res. 2010;70(20):7894-7904
22. Mueller DW Bosserhoff AK. MicroRNA miR-196a controls melanoma-Associated genes by regulating HOX-C8 expression. Int J Cancer. 2011;129(5):1064-1074
23. Hu Z Chen J Tian T et al. Genetic variants of miRNA sequences and non-small cell lung cancer survival. J Clin Invest. 2008;118(7): 2600-2608
24. Zhan JF Chen LH Chen ZX et al. A functional variant in microRNA-196a2 is associated with susceptibility of colorectal cancer in a Chinese population. Arch Med Res. 2011;42(2):144-148
25. Tian T Shu Y Chen J et al. A functional genetic variant in microRNA-196a2 is associated with increased susceptibility of lung cancer in Chinese. Cancer Epidemiol Biomarkers Prev. 2009;18(4): 1183-1187
26. Hoffman AE Zheng T Yi C et al. microRNA miR-196a-2 and breast cancer: A genetic and epigenetic association study and functional analysis. Cancer Res. 2009;69(14):5970-5977
27. Christensen BC Avissar-Whiting M Ouellet LG et al. Mature microRNA sequence polymorphism in MIR196A2 is associated with risk and prognosis of head and neck cancer. Clin Cancer Res. 2010;16(14): 3713-3720
28. Hu Z Liang J Wang Z et al. Common genetic variants in pre-microRNAs were associated with increased risk of breast cancer in Chinese women. Hum Mutat. 2009;30(1):79-84
29. Akkiz H Bayram S Bekar A et al. A functional polymorphism in pre-microRNA-196a-2 contributes to the susceptibility of hepatocellular carcinoma in a Turkish population: A case-control study. J Viral Hepat. 2011;18(7):e399-e407
30. Dou T Wu Q Chen X et al. A polymorphism of microRNA196a genome region was associated with decreased risk of glioma in Chinese population. J Cancer Res Clin Oncol. 2010;136(12): 1853-1859
31. Viatour P Merville MP Bours V et al. Phosphorylation of NF-kappaB and IkappaB proteins: Implications in cancer and inflammation. Trends Biochem Sci. 2005;30(1):43-52
32. Karin M Cao Y Greten FR Li ZW. NF-kappaB in cancer: From innocent bystander to major culprit. Nat Rev Cancer. 2002;2(4):301-310
33. Tamatani M Che YH Matsuzaki H et al. Tumor necrosis factor induces Bcl-2 and Bcl-x expression through NFkappaB activation in primary hippocampal neurons. J Biol Chem. 1999;274(13): 8531-8538
34. Bentires-Alj M Dejardin E Viatour P et al. Inhibition of the NF-kappa B transcription factor increases Bax expression in cancer cell lines. Oncogene. 2001;20(22):2805-2813
35. Swanton E Savory P Cosulich S et al. Bcl-2 regulates a caspase-3/ caspase-2 apoptotic cascade in cytosolic extracts. Oncogene. 1999; 18(10):1781-1787
36. Rossé T Olivier R Monney L et al. Bcl-2 prolongs cell survival after Bax-induced release of cytochrome c. Nature. 1998;391(6666): 496-499
37. Bivona TG Hieronymus H Parker J et al. FAS and NF-kappaB signalling modulate dependence of lung cancersonmutant EGFR.Nature. 2011; 471(7339):523-526
38. Jiang L Lin C Song L et al. MicroRNA-30e. promotes human glioma cell invasiveness in an orthotopic xenotransplantation model by disrupting the NF-kappaB/IkappaBalpha negative feedback loop. J Clin Invest. 2012;122(1):33-47
39. Zhao S Yang GMuY. MiR-106a is anindependent prognostic marker in patients with glioblastoma. Neuro Oncol. 2013;15(6):707-717
40. Jansen M Yip S Louis DN. Molecular pathology in adult gliomas: Diagnostic prognostic and predictive markers. Lancet Neurol. 2010; 9(7):717-726
41. Weller M Felsberg J Hartmann C. Molecular predictors of progression-free and overall survival in patients with newly diagnosed glioblastoma: A prospective translational study of the German Glioma Network. J Clin Oncol. 2009;27(34):5743-5750.